Why do people take part in atrial fibrillation screening? qualitative interview study in English primary care

Why do people take part in atrial fibrillation screening? qualitative interview study in English primary care

<p><strong>Objectives:</strong> There is insufficient evidence to support national screening programmes for atrial fibrillation (AF). Nevertheless, some practitioners, policy-makers and special interest groups have encouraged introduction of opportunistic screening in primary care...

Podrobná bibliografie
Hlavní autoři:	Hoare, S, Powell, A, Modi, RN, Armstrong, N, Griffin, SJ, Mant, J, Burt, J, Hobbs, F
Další autoři:	SAFER Authorship Group
Médium:	Journal article
Jazyk:	English
Vydáno:	BMJ Publishing Group 2022

Podobné jednotky

Why do people take part in atrial fibrillation screening? Qualitative interview study in English primary care
Autor: Richard Hobbs, a další
Vydáno: (2022-03-01)

Why do people choose not to take part in screening? Qualitative interview study of atrial fibrillation screening nonparticipation
Autor: Sarah Hoare, a další
Vydáno: (2023-12-01)

Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial
Autor: Mant, J, a další
Vydáno: (2024)

The feasibility of population screening for paroxysmal atrial fibrillation using hand-held electrocardiogram devices
Autor: Mant, J, a další
Vydáno: (2024)

Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial
Autor: Williams, K, a další
Vydáno: (2022)

Should we screen for atrial fibrillation?
Autor: Lown, M, a další
Vydáno: (2017)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
Autor: Hobbs, F, a další
Vydáno: (2011)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial
Autor: Hobbs, R, a další
Vydáno: (2011)

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
Autor: Mant, J, a další
Vydáno: (2008)

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
Autor: Mavaddat, N, a další
Vydáno: (2014)

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
Autor: van Walraven, C, a další
Vydáno: (2009)

Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".
Autor: Mavaddat, N, a další
Vydáno: (2014)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
Autor: Mant, J, a další
Vydáno: (2007)

Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.
Autor: Mant, J, a další
Vydáno: (2007)

A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
Autor: Hurley, V, a další
Vydáno: (2007)

Stroke prevention in atrial fibrillation
Autor: Hobbs, F
Vydáno: (2003)

Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial
Autor: Martin R Cowie, a další
Vydáno: (2022-09-01)

Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER feasibility study
Autor: Hibbitt, K, a další
Vydáno: (2024)

Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER feasibility study
Autor: Hibbitt, K, a další
Vydáno: (2024)

Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial
Autor: Gregory Y H Lip, a další
Vydáno: (2024-04-01)

A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.
Autor: Roalfe, A, a další
Vydáno: (2012)

Treatment pathways for patients with atrial fibrillation.
Autor: Hodgkinson, J, a další
Vydáno: (2012)

Paroxysmal atrial fibrillation (part II)
Autor: B. A. Tatarsky
Vydáno: (2008-06-01)

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
Autor: Jowett, S, a další
Vydáno: (2011)

Anticoagulant management in patients with atrial fibrillation.
Autor: Fitzmaurice, D, a další
Vydáno: (2009)

Atrial fibrillation and atrial flutter – the state of the art. Part 1
Autor: Agnieszka Janion-Sadowska, a další
Vydáno: (2021-06-01)

An analysis of factors that predict patient consent to take part in a randomized controlled trial.
Autor: Fletcher, K, a další
Vydáno: (2007)

Atrial fibrillation fact sheet in Korea 2024 (part 1): epidemiology of atrial fibrillation in Korea
Autor: So-Ryoung Lee, a další
Vydáno: (2024-07-01)

Impact of study design on recruitment of patients to a primary care trial: an observational time series analysis of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study.
Autor: Fletcher, K, a další
Vydáno: (2010)

How to embed qualitative research in trials: insights from the feasibility study of the SAFER trial programme
Autor: Alison Powell, a další
Vydáno: (2022-05-01)

Paroxysmal forms of atrial fibrillation (part 1)
Autor: B. A. Tatarsky
Vydáno: (2008-04-01)

Management of patients with atrial fibrillation at high risk of stroke: current treatment options
Autor: Edwards D, a další
Vydáno: (2012-06-01)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
Autor: Mant, J, a další
Vydáno: (2003)

Identification and treatment of patients with atrial fibrillation in primary care.
Autor: Hobbs, R
Vydáno: (1999)

Randomised trial of two approaches to screening for atrial fibrillation in UK general practice.
Autor: Morgan, S, a další
Vydáno: (2002)

Rhythm control agents and adverse events in patients with atrial fibrillation.
Autor: Taylor, C, a další
Vydáno: (2010)

Atrial fibrillation fact sheet in Korea 2024 (part 3): treatment for atrial fibrillation in Korea: medicines and ablation
Autor: Yun Gi Kim, a další
Vydáno: (2024-08-01)

Atrial fibrillation fact sheet in Korea 2024: part 2—stroke prevention in Korean patients with atrial fibrillation
Autor: Pil-sung Yang, a další
Vydáno: (2024-08-01)

Nonvalvular atrial fibrillation and acute coronary syndrome: Present Indian perspective and assessment
Autor: Ranjan Modi, a další
Vydáno: (2021-01-01)

Research into practice: management of atrial fibrillation in general practice.
Autor: Fitzmaurice, D, a další
Vydáno: (2014)